Kinesis Pharma Report issue

For profit Phase 1
Founded: Breda Netherlands (1997)
Status: Acquired by Venn Life Sciences (2015)

Organization Overview

First Clinical Trial
2009
NCT01084343
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Kinesis Pharma B.V. | Kinesis Pharma BV, Breda, the Netherlands